Skip to content

About
Our Work
Support SDI
Clinical Labs
SDI Conference
- SDI’s Annual Conference
- Stay Up To Date
Lab Portal
Donate

About
Our Work
Support SDI
Clinical Labs
SDI Conference
- SDI’s Annual Conference
- Stay Up To Date
Lab Portal
Donate

About
Our Work
Support SDI
Clinical Labs
SDI Conference
- SDI’s Annual Conference
- Stay Up To Date
Lab Portal
Donate

About
Our Work
Support SDI
Clinical Labs
SDI Conference
- SDI’s Annual Conference
- Stay Up To Date
Lab Portal
Donate

Protected: The Opportunity for Salivary Diagnostics

Welcome! Session 1 The Opportunity for Salivary Diagnostics

This content is password-protected. To view it, please enter the password below.

Password:

X-twitter Instagram Linkedin Bluesky Logo Facebook

Sitemap

Resources

Support

X-twitter Instagram Linkedin Bluesky Logo Facebook

Important Regulatory Information about SalivaDirect™
SalivaDirect™has not been FDA cleared or approved. It has been authorized by the FDA under an emergency use authorization for use by authorized laboratories. The test has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

© 2026 SalivaDirect, Inc. | Site Designed by Rootless Agency